ADA and rheumatoid arthritis: Additionally, studies were found as meta-analyses, where the presence of anti-drug antibody (ADA) was evaluated in patients with RA and treated with infliximab, etanercept, adalimumab, golimumab, tocilizumab, abatacept, and rituximab.